Moderate intensity statin (other than rosuvastatin 20-40 mg or
atorvastatin 40-80 mg) |
≈ 30% |
High intensity statin (rosuvastatin 20-40 mg or atorvastatin 40-80 mg) |
≈ 50% |
High intensity statin + ezetimibe |
≈ 65% |
PCSK9i as monotherapy |
≈ 60% |
PCSK9i + high intensity statin |
≈ 75% |
PCSK9i + high intensity statin + ezetimibe |
≈ 85% |